Annual report
7090.TEDINET S100R2Y9
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥508m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥159m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥527m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥151m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥240m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥204m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥65m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥886m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥119m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥774m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥157m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥143m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥36m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥777m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥908m | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥353m | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥822m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥160m | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥932m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥282m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥328m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥80m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥207m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥367m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥604m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥475m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥496m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥226m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥52m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥720m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥154m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥509m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥137m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-552.13 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.64 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.5 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.96 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.18 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.55 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.43 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥129.49 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥251.71 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥811.24 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥761.05 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥631.64 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥157.92 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 10.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 29.1% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 159 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 156 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 121 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 85 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 82 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥1.2bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥448m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥36m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥458m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥30m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥118m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥162m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥41m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥17m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥716m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥6m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥72m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥112m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥17m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥783m | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥246m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥979m | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥959m | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥808m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥176m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥826m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥864m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-510.42 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.01 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.3 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.01 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.31 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥3.92 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.52 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.58 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥174.98 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥693.47 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥689.6 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥620.81 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥174.39 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 9.7% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.6% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,418,800 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,415,800 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,391,100 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,301,500 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,011,900 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 68 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 77 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 61 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 57 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 55 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Financial Services Segmentsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥33m |
| Financial Services Segmentsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥5m |
| Financial Services Segmentsreportable segment | employees | at 2023-03-31 | 44 pure |
| Financial Services Segmentsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥798m |
| Financial Services Segmentsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥798m |
| Financial Services Segmentsreportable segment | segment assets | at 2023-03-31 | ¥170m |
| Financial Services Segmentsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥107m |
| Osteopathic Solution Segmentsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥98m |
| Osteopathic Solution Segmentsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥222m |
| Osteopathic Solution Segmentsreportable segment | employees | at 2023-03-31 | 115 pure |
| Osteopathic Solution Segmentsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Osteopathic Solution Segmentsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Osteopathic Solution Segmentsreportable segment | segment assets | at 2023-03-31 | ¥3.2bn |
| Osteopathic Solution Segmentsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥401m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥131m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥227m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| —segment total | segment assets | at 2023-03-31 | ¥3.4bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥508m |
| Financial Services Segmentsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Financial Services Segmentsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Financial Services Segmentsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | segment assets | at 2022-03-31 | ¥214m |
| Financial Services Segmentsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥24m |
| Osteopathic Solution Segmentsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥303m |
| Osteopathic Solution Segmentsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥190m |
| Osteopathic Solution Segmentsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Osteopathic Solution Segmentsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Osteopathic Solution Segmentsreportable segment | segment assets | at 2022-03-31 | ¥3.1bn |
| Osteopathic Solution Segmentsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥134m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥308m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥192m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | segment assets | at 2022-03-31 | ¥3.3bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥159m |
| Osteopathic Solution Segmentsreportable segment | employees | at 2023-03-31 | 68 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,264
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 77 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 68 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 3 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 7 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 6 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 2 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 3.740 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 2.706 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.571 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.940 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.274 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.209 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 115 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 8 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 44 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 2 | |
| Number of employees | CurrentYearInstant | 159 | |
| Average number of temporary workers | CurrentYearInstant | 10 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 68 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | － | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 32.5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4.3 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4339000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 68 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | － | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 130929000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 97744000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 33185000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1418800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1418800 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1418800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1418800 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 13 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 21 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 9 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 545 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 589 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 328 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 700 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |